89 related articles for article (PubMed ID: 27662548)
21. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
Thorne C; Newell ML
Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
[TBL] [Abstract][Full Text] [Related]
22. General 4-week toxicity study with EMS in the rat.
Pfister T; Eichinger-Chapelon A
Toxicol Lett; 2009 Nov; 190(3):271-85. PubMed ID: 19442710
[TBL] [Abstract][Full Text] [Related]
23. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
[TBL] [Abstract][Full Text] [Related]
24. Risk of birth defects associated with nelfinavir exposure during pregnancy.
Covington DL; Conner SD; Doi PA; Swinson J; Daniels EM
Obstet Gynecol; 2004 Jun; 103(6):1181-9. PubMed ID: 15172850
[TBL] [Abstract][Full Text] [Related]
25. Modelling of patient EMS exposure: translating pharmacokinetics of EMS in vitro and in animals into patients.
Lavé T; Paehler A; Grimm HP; Gocke E; Müller L
Toxicol Lett; 2009 Nov; 190(3):310-6. PubMed ID: 19695316
[TBL] [Abstract][Full Text] [Related]
26. Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.
Rudin C; Burri M; Shen Y; Rode R; Nadal D; ;
Pediatr Infect Dis J; 2008 May; 27(5):431-7. PubMed ID: 18382386
[TBL] [Abstract][Full Text] [Related]
27. Solid cancer incidence in atomic bomb survivors exposed in utero or as young children.
Preston DL; Cullings H; Suyama A; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K; Kasagi F; Shore RE
J Natl Cancer Inst; 2008 Mar; 100(6):428-36. PubMed ID: 18334707
[TBL] [Abstract][Full Text] [Related]
28. Drug design: new inhibitors for HIV-1 protease based on Nelfinavir as lead.
Perez MA; Fernandes PA; Ramos MJ
J Mol Graph Model; 2007 Oct; 26(3):634-42. PubMed ID: 17459746
[TBL] [Abstract][Full Text] [Related]
29. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children.
Resino S; Larrú B; Maria Bellón J; Resino R; de José MI; Navarro M; Léon JA; Ramos JT; Mellado MJ; Muñoz-Fernández MA
BMC Infect Dis; 2006 Jul; 6():107. PubMed ID: 16834769
[TBL] [Abstract][Full Text] [Related]
30. The effect of maternal exposure to psychosocial job strain on pregnancy outcomes and child development.
Larsen AD
Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634513
[TBL] [Abstract][Full Text] [Related]
31. In vivo genotoxicity of EMS: statistical assessment of the dose response curves.
Gocke E; Wall M
Toxicol Lett; 2009 Nov; 190(3):298-302. PubMed ID: 19857797
[TBL] [Abstract][Full Text] [Related]
32. The Effects of Maternal Obesity on Neonates, Infants, Children, Adolescents, and Adults.
Hemond J; Robbins RB; Young PC
Clin Obstet Gynecol; 2016 Mar; 59(1):216-27. PubMed ID: 26694497
[TBL] [Abstract][Full Text] [Related]
33. Congenital malformations in the newborn--a prospective study.
Mishra PC; Baveja R
Indian Pediatr; 1989 Jan; 26(1):32-5. PubMed ID: 2788132
[TBL] [Abstract][Full Text] [Related]
34. [Birth defects in a cohort of uninfected children born to HIV-infected women].
Fernández Ibieta M; Ramos Amador JT; Bellón Cano JM; González-Tomé MI; Guillén Martín S; Navarro Gómez M; de José MI; Beceiro J; Iglesias E; Prieto L; Santos MJ; Martínez Guardia N; Roa MA; Regidor J
An Pediatr (Barc); 2009 Mar; 70(3):253-64. PubMed ID: 19246263
[TBL] [Abstract][Full Text] [Related]
35. [Epidemiologic methods in teratology].
Saxén L; Karkinen-Jääskeläinen M; Saxén I
Duodecim; 1974; 90(22):1554-64. PubMed ID: 4455479
[No Abstract] [Full Text] [Related]
36. Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy.
Reiser M; Salzberger B; Stiepel A; Hoetelmans R; Diehl V; Fätkenheuer G
Eur J Med Res; 1999 Feb; 4(2):54-8. PubMed ID: 10066640
[TBL] [Abstract][Full Text] [Related]
37. Non-cancer EMF effects related to children.
Feychting M
Bioelectromagnetics; 2005; Suppl 7():S69-74. PubMed ID: 16142774
[TBL] [Abstract][Full Text] [Related]
38. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study.
Mussi-Pinhata MM; Freimanis L; Yamamoto AY; Korelitz J; Pinto JA; Cruz ML; Losso MH; Read JS;
Pediatrics; 2007 Mar; 119(3):e694-704. PubMed ID: 17296782
[TBL] [Abstract][Full Text] [Related]
39. Twice-daily dosing of Nelfinavir approved.
Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366888
[TBL] [Abstract][Full Text] [Related]
40. Safety of nelfinavir use during pregnancy. An experimental approach in rats.
Mathias CV; Mathias CF; Simões MJ; Amed AM; Simões RS; Oliveira-Filho RM; Kulay L
Clin Exp Obstet Gynecol; 2005; 32(3):163-5. PubMed ID: 16433154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
